Sven van Eijl

1.2k citations
10 papers · 885 indexed · h-index 8
Topics
Pulmonary Hypertension Research and Treatments (2 papers)Acute Myocardial Infarction Research (2 papers)Animal testing and alternatives (2 papers)

In The Last Decade

Sven van Eijl

10 papers receiving 875 citations

Peers

Sven van Eijl
Comparison fields: 5 of 111
  • Molecular Biology 206
  • Physiology 201
  • Pulmonary and Respiratory Medicine 171
  • Cardiology and Cardiovascular Medicine 160
  • Oncology 160
Replace Uğur Atik with:
Uğur Atik Türkiye
Steven C. Griffen United States
Irit Maor Israel
Chang Yeop Han United States
Dorota Formanowicz Poland
Niels Kloosterhuis Netherlands
Remise Gelışgen Türkiye
G. Palladini Italy
Kuang‐Chung Shih Taiwan
M D Nyby United States
Sven van Eijl relative to Uğur Atik Türkiye Uğur Atik's profile →
Citations per field
00.5×3.1×
Uğur Atik · 1×
Citations per year

Countries citing papers authored by Sven van Eijl

Since Specialization
Citations

This map shows the geographic impact of Sven van Eijl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven van Eijl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven van Eijl more than expected).

Fields of papers citing papers by Sven van Eijl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven van Eijl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven van Eijl. The network helps show where Sven van Eijl may publish in the future.

Co-authorship network of co-authors of Sven van Eijl

This figure shows the co-authorship network connecting the top 25 collaborators of Sven van Eijl. A scholar is included among the top collaborators of Sven van Eijl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven van Eijl. Sven van Eijl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 122
3 206
4 79
5 70
6 13
7 1
8 162
9 28
10 198

About Sven van Eijl

Sven van Eijl is a scholar working on Behavioral Neuroscience, Small Animals and Pharmacology, having authored 10 papers that have together received 885 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (2 papers), Acute Myocardial Infarction Research (2 papers) and Animal testing and alternatives (2 papers). The work is most often cited by research in Biochemistry (99 citations), Periodontics (46 citations) and Physiology (201 citations). Sven van Eijl has collaborated with scholars based in United Kingdom, Netherlands and Germany. Frequent co-authors include Els Wagenaar, Johan W. Jonker, Alfred H. Schinkel, Amrita Ahluwalia, Krishnaraj S. Rathod, Shanti Velmurugan, Rayomand S. Khambata, Gunter Kuhnle, Tahseen A Chowdhury and Michael A. Curtis. Their work appears in journals such as Circulation, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026